2012 annual financial data
Viridian Therapeutics 2012 Financial results
Direct answer
Revenue was 4.41M USD.
Operating income was -4.03M USD and net income was -7.21M USD.
Operating cash flow was -6.22M USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4.41M USD
- Operating income
- -4.03M USD
- Net income
- -7.21M USD
- Operating cash flow
- -6.22M USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Viridian Therapeutics financial years